Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The tumor suppressor WARTS activates the Omi / HtrA2-dependent pathway of cell death

Abstract

Drosophila tumor suppressor WARTS (Wts) is an evolutionally conserved serine / threonine kinase and participates in a signaling complex that regulates both proliferation and apoptosis to ensure the proper size and shape of the fly. Human counterparts of this complex have been found to be frequently downregulated or mutated in cancers. WARTS, a human homolog of Wts, is also known as tumor suppressor and mitotic regulator, but its molecular implications in tumorigenesis are still obscure. Here, we show that WARTS binds via its C-terminus to the PDZ domain of a proapoptotic serine protease Omi / HtrA2. Depletion of WARTS inhibited Omi / HtrA2-mediated cell death, whereas overexpression of WARTS promoted this process. Furthermore, WARTS can enhance the protease activity of Omi / HtrA2 both in vivo and in vitro. Activation of Omi / HtrA2-mediated cell death is thus a potential mechanism for the tumor suppressive activity of WARTS.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Abrams JM . (2002). Cell, 110, 403–406.

  • Brummelkamp TR, Bernards R and Agami R . (2002). Science, 296, 550–553.

  • Cilenti L, Soundarapandian MM, Kyriazis GA, Stratico V, Singh S, Gupta S, Bonventre JV, Alnemri ES and Zervos AS . (2004). J. Biol. Chem., 279, 50295–50301.

  • Conlon I and Raff M . (1999). Cell, 96, 235–244.

  • Cory S and Adams JM . (2002). Nat. Rev. Cancer, 2, 647–656.

  • Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T . (2001). Nature, 411, 494–498.

  • Evan GI, Brown L, Whyte M and Harrington E . (1995). Curr. Opin. Cell Biol., 7, 825–834.

  • Faccio L, Fusco C, Chen A, Martinotti S, Bonventre JV and Zervos AS . (2000). J. Biol. Chem., 275, 2581–2588.

  • Gray CW, Ward RV, Karran E, Turconi S, Rowles A, Viglienghi D, Southan C, Barton A, Fantom KG, West A, Savopoulos J, Hassan NJ, Clinkenbeard H, Hanning C, Amegadzie B, Davis JB, Dingwall C, Livi GP and Creasy CL . (2000). Eur. J. Biochem., 267, 5699–5710.

  • Green DR and Evan GI . (2002). Cancer Cell., 1, 19–30.

  • Harvey KF, Pfleger CM and Hariharan IK . (2003). Cell, 114, 457–467.

  • Harvey KJ, Lukovic D and Ucker DS . (2000). J. Cell Biol., 148, 59–72.

  • Hegde R, Srinivasula SM, Zhang Z, Wassell R, Mukattash R, Cilenti L, DuBois G, Lazebnik Y, Zervos AS, Fernandes-Alnemri T and Alnemri ES . (2002). J. Biol. Chem., 277, 432–438.

  • Hirota T, Morisaki T, Nishiyama Y, Marumoto T, Tada K, Hara T, Masuko N, Inagaki M, Hatakeyama K and Saya H . (2000). J. Cell Biol., 149, 1073–1086.

  • Hisaoka M, Tanaka A and Hashimoto H . (2002). Lab. Invest., 82, 1427–1435.

  • Holley CL, Olson MR, Colon-Ramos DA and Kornbluth S . (2002). Nat. Cell Biol., 4, 439–444.

  • Huse M and Kuriyan J . (2002). Cell, 109, 275–282.

  • Iida S, Hirota T, Morisaki T, Marumoto T, Hara T, Kuninaka S, Honda S, Kosai K, Kawasuji M, Pallas DC and Saya H . (2004). Oncogene, 23, 5266–5274.

  • Jones JM, Datta P, Srinivasula SM, Ji W, Gupta S, Zhang Z, Davies E, Hajnoczky G, Saunders TL, Van Keuren ML, Fernandes-Alnemri T, Meisler MH and Alnemri ES . (2003). Nature, 425, 721–727.

  • Justice RW, Zilian O, Woods DF, Noll M and Bryant PJ . (1995). Genes Dev., 9, 534–546.

  • Leist M and Jaattela M . (2001). Nat. Rev. Mol. Cell. Biol., 2, 589–598.

  • Li W, Srinivasula SM, Chai J, Li P, Wu JW, Zhang Z, Alnemri ES and Shi Y . (2002). Nat. Struct. Biol., 9, 436–441.

  • Makino K, Kuwahara H, Masuko N, Nishiyama Y, Morisaki T, Sasaki J, Nakao M, Kuwano A, Nakata M, Ushio Y and Saya H . (1997). Oncogene, 14, 2425–2433.

  • Martins LM, Iaccarino I, Tenev T, Gschmeissner S, Totty NF, Lemoine NR, Savopoulos J, Gray CW, Creasy CL, Dingwall C and Downward J . (2002). J. Biol. Chem., 277, 439–444.

  • Martins LM, Turk BE, Cowling V, Borg A, Jarrell ET, Cantley LC and Downward J . (2003). J. Biol. Chem., 278, 49417–49427.

  • Morisaki T, Hirota T, Iida S, Marumoto T, Hara T, Nishiyama Y, Kawasuzi M, Hiraoka T, Mimori T, Araki N, Izawa I, Inagaki M and Saya H . (2002). FEBS Lett., 529, 319–324.

  • Morita S, Kojima T and Kitamura T . (2000). Gene Therapy, 7, 1063–1066.

  • Nishiyama Y, Hirota T, Morisaki T, Hara T, Marumoto T, Iida S, Makino K, Yamamoto H, Hiraoka T, Kitamura N and Saya H . (1999). FEBS Lett., 459, 159–165.

  • Pantalacci S, Tapon N and Leopold P . (2003). Nat. Cell Biol., 5, 921–927.

  • Ryoo HD, Bergmann A, Gonen H, Ciechanover A and Steller H . (2002). Nat. Cell Biol., 4, 432–438.

  • Salvesen GS and Duckett CS . (2002). Nat Rev. Mol. Cell. Biol., 3, 401–410.

  • Schmitt CA and Lowe SW . (1999). J. Pathol., 187, 127–137.

  • Srinivasula SM, Gupta S, Datta P, Zhang Z, Hegde R, Cheong N, Fernandes-Alnemri T and Alnemri ES . (2003). J. Biol. Chem., 278, 31469–31472.

  • Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J, Lee RA, Robbins PD, Fernandes-Alnemri T, Shi Y and Alnemri ES . (2001). Nature, 410, 112–116.

  • St John MA, Tao W, Fei X, Fukumoto R, Carcangiu ML, Brownstein DG, Parlow AF, McGrath J and Xu T . (1999). Nat. Genet., 21, 182–186.

  • Sudo T, Ota Y, Kotani S, Nakao M, Takami Y, Takeda S and Saya H . (2001). EMBO J., 20, 6499–6508.

  • Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K and Takahashi R . (2001). Mol. Cell, 8, 613–621.

  • Suzuki Y, Takahashi-Niki K, Akagi T, Hashikawa T and Takahashi R . (2004). Cell. Death Differ., 11, 208–216.

  • Tao W, Zhang S, Turenchalk GS, Stewart RA, St John MA, Chen W and Xu T . (1999). Nat. Genet., 21, 177–181.

  • Tapon N, Harvey KF, Bell DW, Wahrer DC, Schiripo TA, Haber DA and Hariharan IK . (2002). Cell, 110, 467–478.

  • Trencia A, Fiory F, Maitan MA, Vito P, Barbagallo AP, Perfetti A, Miele C, Ungaro P, Oriente F, Cilenti L, Zervos AS, Formisano P and Beguinot F . (2004). J. Biol. Chem., 279, 46566–46572.

  • Tsuruta F, Masuyama N and Gotoh Y . (2002). J. Biol. Chem., 277, 14040–14047.

  • Udan RS, Kango-Singh M, Nolo R, Tao C and Halder G . (2003). Nat. Cell Biol., 5, 914–920.

  • Verhagen AM, Silke J, Ekert PG, Pakusch M, Kaufmann H, Connolly LM, Day CL, Tikoo A, Burke R, Wrobel C, Moritz RL, Simpson RJ and Vaux DL . (2002). J. Biol. Chem., 277, 445–454.

  • Wang X . (2001). Genes Dev., 15, 2922–2933.

  • Wu S, Huang J, Dong J and Pan D . (2003). Cell, 114, 445–456.

  • Xu T, Wang W, Zhang S, Stewart RA and Yu W . (1995). Development, 121, 1053–1063.

  • Yang QH, Church-Hajduk R, Ren J, Newton ML and Du C . (2003). Genes Dev., 17, 1487–1496.

  • Yang X, Yu K, Hao Y, Li DM, Stewart R, Insogna KL and Xu T . (2004). Nat. Cell Biol., 6, 609–617.

  • Yang Y, Fang S, Jensen JP, Weissman AM and Ashwell JD . (2000). Science, 288, 874–877.

  • Yoo SJ, Huh JR, Muro I, Yu H, Wang L, Wang SL, Feldman RM, Clem RJ, Muller HA and Hay BA . (2002). Nat. Cell Biol., 4, 416–424.

Download references

Acknowledgements

We thank T Kitamura for the pMXpuro vector and Plat-E cells; Y Hata for the pClneoMyc APC expression plasmid; H Kuwahara for recombinant NE-dlg and PSD95 proteins; M Nakajima for helpful discussion; members of the Saya lab for valuable help and suggestions; and members of the Gene Technology Center at Kumamoto University for technical assistance. SK is a postdoctoral fellow of the Japan Society for the Promotion of Science (JSPS). This work was supported by the Research for the Future Program of the Japan Society for the promotion of Science and by a grant for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to HS).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hideyuki Saya.

Additional information

Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuninaka, S., Nomura, M., Hirota, T. et al. The tumor suppressor WARTS activates the Omi / HtrA2-dependent pathway of cell death. Oncogene 24, 5287–5298 (2005). https://doi.org/10.1038/sj.onc.1208682

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208682

Keywords

This article is cited by

Search

Quick links